Tampa Free Press on MSNOpinion
Op-Ed: Congress Needs To Reform PBMs Now, Not Embrace Government Price Controls
Floridians know too well that the cost of prescription drugs can feel like a second mortgage. From seniors on fixed incomes ...
Medicare Part B premiums are jumping 12% in 2026. Learn about new costs, Advantage plan cuts, and the enrollment deadline ...
Wellbeing Whisper on MSN
Rising GLP-1 Drug Use Forces Employers Into Costly Coverage Dilemmas
What happens when a benefit designed to attract the best talent starts siphoning millions out of the budget? That’s what many ...
"Of all the technology companies in the U.S., ranking 12 on Deloitte's Technology Fast 500 is an enormous achievement by our entire organization," said Tom Dorsett, CEO and Co-founder of RazorMetrics.
The state’s Medical Board has issued clear, evidence-based guidelines that recommend starting with non-opioid medications for ...
"Of all the technology companies in the U.S., ranking 12 on Deloitte's Technology Fast 500 is an enormous achievement by our entire organization," said Tom Dorsett, CEO and Co-founder of RazorMetrics.
In a verbal sparring over who can deliver the lowest drug prices in the U.S., several Senate Democrats are urging President ...
Lowering patients' drug costs requires reforms to the PBM market. These reforms should address PBMs' growing use of group ...
More than half of Americans age 65 or older are taking four or more prescription medications; 12 percent are taking at least ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback